A hand that fell asleep under your pillow wakes up within a minute or two. The version that brings people to a doctor’s office looks different: numbness or tingling in your hands and feet that shows up without a clear trigger, involves both sides, and keeps returning across weeks. That pattern has a primary care workup behind it, and the workup starts with blood rather than with a nerve test.
Clinicians call the pins-and-needles feeling paresthesia, a change in sensation with no outside cause to explain it. When the source is damage or dysfunction in the nerves outside the brain and spinal cord, the umbrella term is peripheral neuropathy. Neither word identifies a cause on its own. They describe what you feel and which part of the nervous system it comes from.
The typical shape of these symptoms is symmetric and distal. Both feet are often involved before both hands, toes and fingertips before ankles and wrists, and the change builds over months instead of arriving in a single afternoon. Symmetric distal symptoms in that shape point toward the metabolic and nutritional causes a blood draw can find, which is why a physician’s first questions are about timing, spread, and whether the two sides match.
These symptoms are common. A 2020 American Family Physician review of peripheral neuropathy evaluation reported a general-population prevalence of 1% to 7%, with higher rates among adults older than 50 (AAFP, 2020). Persistent sensation changes still belong with the other symptoms you should never ignore in primary care, because the shape of the pattern matters more than how common it is. What causes numbness in hands and feet has a handful of frequent answers and many rare ones, and a primary care visit works through the frequent ones first.
The four checks that come first in primary care
The first-line evaluation for symmetric, distal numbness and tingling in primary care covers four checks: vitamin B12, a fasting blood glucose or hemoglobin A1C, a thyroid-stimulating hormone (TSH) level, and a review of your current medication list. Each one names a common and often correctable cause of nerve symptoms.
That grouping comes from published guidance. The 2020 American Family Physician review lists fasting blood glucose, vitamin B12, and TSH as the recommended initial laboratory workup for symmetric distal polyneuropathy, and reports the highest-yield findings among them as elevated glucose in 11% of patients and low B12 in 3.6% (AAFP, 2020). The approach has a long track record: the American Academy of Neurology’s 2008 practice guideline recommended blood glucose, B12, and serum protein testing for all patients with numb, painful feet, as tests that can often point to the common causes of neuropathy (AAN, 2008). AAFP puts the specialized testing after that step: if the initial evaluation is inconclusive, it recommends considering referral to a neurologist for additional testing (AAFP).
Each of the four checks answers a different question about a different common cause, and each one describes what a physician evaluates rather than what your symptoms mean.
Vitamin B12 and the nutritional causes
Low vitamin B12 is one of the more useful findings on this panel, because it is measurable and often correctable. The NIH Office of Dietary Supplements estimates that B12 deficiency affects 3% to 43% of older adults, largely because many older adults no longer produce enough stomach acid to absorb the B12 that occurs naturally in food (NIH Office of Dietary Supplements, updated June 2026). Diet explains part of that picture after 50, and absorption accounts for much of the rest.
Peripheral neuropathy is a recognized neurologic manifestation of low B12, which is the reason a physician tests the level instead of waiting for a fuller clinical picture to develop (StatPearls, Vitamin B12 Deficiency). AAFP’s review found low B12 in 3.6% of patients evaluated for neuropathy, a small share of the total and a meaningful one when it turns out to be yours.
What people describe as numbness from a B12 deficiency, or as tingling from low vitamin levels, tends to be the same symmetric, distal pattern the panel is built around. A physician seldom orders a B12 level by itself. It goes on the same lab order as the other vitamin and nutrient deficiencies routine blood work can catch, so one draw can answer several questions at once.
Blood sugar, A1C, and nerve damage from diabetes
Blood sugar is the highest-yield item on the first-line panel. AAFP’s review reported elevated glucose in 11% of patients evaluated for peripheral neuropathy, the largest single share among the recommended tests (AAFP, 2020). A fasting blood glucose or an A1C test answers the question at the cost of one draw, and both are already ordinary parts of adult care.
The National Institute of Diabetes and Digestive and Kidney Diseases estimates that about one-third to one-half of people with diabetes have peripheral neuropathy (NIDDK). That page was last reviewed in 2018, so the figure reads best as the agency’s standing estimate rather than a fresh measurement. Even at the low end, the share is large enough that numbness in the feet belongs in the same conversation as glucose control, and how primary care manages type 2 diabetes covers the monitoring side of that work.
In some cases the sensation change prompts the first blood sugar test, not the reverse, which is what an 11% yield on glucose among patients worked up for nerve symptoms implies. When a result comes back high, the follow-up takes a longer view of the same question. What your A1C number means explains how one number summarizes a longer stretch of glucose control than a single morning’s draw can.
Thyroid function and the TSH test
Thyroid disease earns a place on the panel because it can produce nerve symptoms in more than one shape. AAFP’s review lists both hypothyroidism and hyperthyroidism among the causes of symmetric distal sensorimotor neuropathy, so an underactive or an overactive thyroid can produce the same symmetric pattern the panel is built around (AAFP, 2020).
One inexpensive test covers that whole branch of the workup. A TSH level is drawn with the rest of the panel, and thyroid testing through primary care walks through what the results may show.
An abnormal result opens its own routine rather than closing the question. TSH monitoring for hypothyroidism describes the recheck-and-adjust rhythm that follows a thyroid diagnosis, so your physician may review the sensation change and the lab numbers together at those follow-up visits.
The reason blood work usually comes before a nerve conduction study
A nerve conduction study measures how fast and how strongly an electrical signal travels along a nerve, and it is the test most people picture when they think of a neuropathy workup. StatPearls’ chapter on electrodiagnostic evaluation describes what the study delivers: a characterization of the pattern of nerve damage, axonal or demyelinating, sensory or motor, focal or diffuse (StatPearls, Electrodiagnostic Evaluation of Peripheral Neuropathy). Blue Point’s explainer on how a nerve conduction study identifies the source of numbness and pain covers the procedure itself.
The pattern narrows the field, and a physician still assembles the cause from other evidence. That same chapter puts history taking, physical examination, and the electrodiagnostic pattern together as integral to the evaluation, and adds that the physician performing the study ideally has the relevant history, exam, and lab findings in hand before it begins (StatPearls). A physician reading a sensory axonal neuropathy result learns a great deal about the type of damage while the question of why it happened stays open, which is where the blood work comes back in. For patients weighing the test itself, when you might need a nerve conduction study sets out the situations in which a physician raises it, a separate question from what the result proves on its own.
The study also has a known blind spot. StatPearls notes it is limited in detecting small-fiber neuropathy, so a normal result does not close the question for every patient (StatPearls). Symptoms arising from the smallest nerve fibers can sit outside what the tracing measures, which is one more reason a physician keeps the history and the physical findings in view after the result comes back. The clinical judgment about which patients the test serves, and at what point in the workup, is the subject of when doctors recommend a nerve conduction study.
Sequence matters for a practical reason. AAFP’s review cites a study in which early electrodiagnostic testing changed the diagnosis or the management plan in two of 368 patients when it was used as a first step (AAFP, 2020). The first-line panel, by comparison, catches the highest-yield reversible causes for the price of one blood draw. No guideline makes labs-before-nerve-study a rule, so the usual order follows from that arithmetic rather than from a mandate. Anyone who wants the procedural detail first can read what to expect during a nerve conduction study.
In primary care, the study tends to earn its place after the panel: when the labs come back unremarkable, when the exam points at something focal or one-sided, or when a physician needs the pattern in hand before making a referral decision. By that point the study has a specific question in front of it, and the physician has lab results to read the damage pattern against. How nerve testing identifies causes of persistent pain covers that handoff from the testing side.
Symptoms that change the timeline
Gradual, symmetric symptoms get a routine workup. A small number of presentations change that timeline, and they differ in kind, not in degree. When to worry about tingling hands comes down to how fast the symptoms arrived, whether the two sides match, whether strength is involved, and whether anything else changed alongside them.
The first of the five is sudden onset. AAFP lists acute onset and asymmetrical presentation among the findings that should prompt referral for electrodiagnostic studies rather than a routine workup alone (AAFP, 2020). Those two get handled on a different track because of an overlap with stroke: the CDC lists sudden numbness or weakness of the face, arm, or leg, especially on one side of the body, among the warning signs of stroke, and directs anyone with those signs to call 911, since the treatment window is time-sensitive (CDC). Sudden one-sided numbness goes to emergency services. It does not wait for a scheduled appointment.
Loss of strength carries different information than a change in sensation does. Common peripheral neuropathy starts out sensory and distal, with strength preserved early on, so AAFP treats predominant motor symptoms as atypical and referral-worthy (AAFP). Patients describe a foot that drops or a grip that fails as weakness rather than tingling, and that difference changes what happens next.
An ascending pattern carries the most specific name of the five. StatPearls’ chapter on Guillain-Barré syndrome describes a classic presentation of ascending weakness, with the lower extremities involved before the upper ones, reaching its worst within about two weeks in typical cases and usually plateauing inside four, and it calls the syndrome a neurologic emergency (StatPearls, Guillain-Barré Syndrome). AAFP’s rapidly progressive clinical course criterion points the same direction (AAFP). Numbness and weakness that climb from the feet toward the hands over days are evaluated as an emergency presentation rather than at the next open appointment.
One combination brings in a different specialty altogether. New numbness or tingling that comes with a change in bladder or bowel control, or with numbness in the saddle area, meaning the inner thighs, groin, or the area you would sit on, is evaluated the same day, not at a routine follow-up. StatPearls describes that combination as cauda equina syndrome and as a neurosurgical emergency, listing bladder dysfunction, bowel dysfunction, and saddle numbness as components of one presentation, with urgent MRI as the standard evaluation (StatPearls, Cauda Equina and Conus Medullaris Syndromes). A physician will ask about bladder and bowel function even when that is not why you came in.
None of these five presentations is a diagnosis you can make at home, and naming them settles the routing rather than the label. Ongoing, gradual symptoms are what primary care is built to work through, and why choose primary care over urgent care for ongoing symptoms makes that case in more detail. Sudden, one-sided, weakness-dominant, ascending, or bladder-and-bowel presentations are the exceptions that skip the queue.
The primary care visit itself, from history to lab draw
The appointment starts with questions rather than needles. A physician will ask when the sensation started, whether it began in the feet or the hands, whether the two sides match, what medications you take, and what your health history and family history contain. The physical exam checks sensation, reflexes, and strength.
The timing answer shapes the rest of the visit, since a change you noticed over months and one that arrived in an hour lead in different directions. Those answers guide which tests a physician orders, so the first-line panel is not automatic for everyone who walks in with tingling.
At Blue Point Medical Group in Las Vegas we keep the lab under one roof, so the draw follows the visit in the same building. Our primary care services and on-site blood specimen collection run together, which is the practical reason the primary care route is often faster than waiting on a referral before any testing begins.
The resulting conversation is where the sequencing pays off. Understanding your lab results covers how to read a report in general terms, and your physician can set the specific numbers beside the symptoms you described at the start of the visit. That conversation covers which of the four common causes the panel ruled out as much as which one it found, since both directions change the next step.
Normal results still carry information. AAFP’s review reports that 25% to 46% of peripheral neuropathy cases end up idiopathic, meaning no cause is identified even after a workup (AAFP, 2020). A clean panel has ruled out the common and correctable explanations, which narrows the field, and that is the point where a nerve conduction study or a neurology referral enters the conversation with a purpose behind it.
The next step before an appointment is a small one. Noting when the symptoms started, which limbs are involved, and what sits in the medicine cabinet gives a physician most of what the visit needs to decide which of the four checks to run first.
Frequently Asked Questions
Can numbness caused by vitamin B12 deficiency be reversed?
Peripheral neuropathy is a recognized neurologic manifestation of low vitamin B12, and correcting a low B12 level is part of how physicians manage it (StatPearls, Vitamin B12 Deficiency). How much sensation returns, and over what timeframe, varies between patients. Your physician can explain what the level, the duration, and the rest of your health history suggest in your own case.
Can numbness in the feet appear before a diabetes diagnosis?
Nerve symptoms sometimes come first. AAFP’s review found elevated glucose in 11% of patients being evaluated for peripheral neuropathy, which means the nerve symptoms were the reason those patients were tested at all (AAFP, 2020). NIDDK estimates that about one-third to one-half of people with diabetes have peripheral neuropathy, on a page last reviewed in 2018 (NIDDK). A sensation change in the feet is one of the symptoms that can start the blood sugar conversation rather than follow it.
Do I need to fast before blood work for numbness or tingling?
That depends on which test the physician orders. A fasting blood glucose carries a preparation requirement that a B12 level and a TSH level do not, and the instruction comes from the ordering physician rather than from a general rule. Understanding how fasting affects blood test results explains why the requirement exists for some panels, and confirming it with the office when the order is placed saves a second trip.
Conclusion
Persistent numbness or tingling in the hands and feet can have many possible causes, and the pattern of the symptoms often helps determine where the evaluation should begin. In primary care, checking vitamin B12, blood sugar, thyroid function, and current medications can identify several common and potentially correctable explanations before more specialized testing is considered.
If your symptoms are gradual, recurring, or affecting both sides, a primary care visit can help determine which tests make sense based on your history and physical exam. Sudden one-sided numbness, significant weakness, rapidly ascending symptoms, or changes in bladder or bowel control require more urgent evaluation.
If you are experiencing ongoing numbness or tingling in your hands or feet, schedule an appointment with Blue Point Medical Group. Our primary care team can review your symptoms, medications, and health history and help determine which initial tests may be appropriate.
This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider for questions about your health or before making changes to your treatment plan.
